Research ArticleArticle
Correction of ΔF508-CFTR trafficking defect by the bioavailable compound glafenine
Renaud Robert, Graeme C Carlile, Jie Liao, Haouaria Balghi, Pierre Lesimple, Na Liu, Bart Kus, Daniela Rotin, Martina Wilke, Hugo R de Jonge, Bob J Scholte, David Y Thomas and John W Hanrahan
Molecular Pharmacology March 3, 2010, mol.109.062679; DOI: https://doi.org/10.1124/mol.109.062679
Renaud Robert
Graeme C Carlile
Jie Liao
Haouaria Balghi
Pierre Lesimple
Na Liu
Bart Kus
Daniela Rotin
Martina Wilke
Hugo R de Jonge
Bob J Scholte
David Y Thomas
Jump to comment:
No eLetters have been published for this article.
In this issue
Molecular Pharmacology
Vol. 105, Issue 4
1 Apr 2024
Research ArticleArticle
Correction of ΔF508-CFTR trafficking defect by the bioavailable compound glafenine
Renaud Robert, Graeme C Carlile, Jie Liao, Haouaria Balghi, Pierre Lesimple, Na Liu, Bart Kus, Daniela Rotin, Martina Wilke, Hugo R de Jonge, Bob J Scholte, David Y Thomas and John W Hanrahan
Molecular Pharmacology March 3, 2010, mol.109.062679; DOI: https://doi.org/10.1124/mol.109.062679
Research ArticleArticle
Correction of ΔF508-CFTR trafficking defect by the bioavailable compound glafenine
Renaud Robert, Graeme C Carlile, Jie Liao, Haouaria Balghi, Pierre Lesimple, Na Liu, Bart Kus, Daniela Rotin, Martina Wilke, Hugo R de Jonge, Bob J Scholte, David Y Thomas and John W Hanrahan
Molecular Pharmacology March 3, 2010, mol.109.062679; DOI: https://doi.org/10.1124/mol.109.062679
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement